Merck Total Liabilities and Share Holders Equity 2010-2024 | MRK

Merck total liabilities and share holders equity for the quarter ending June 30, 2024 was $112.630B, a 7.81% increase year-over-year.

  • Merck total liabilities and share holders equity for 2023 was $106.675B, a 2.28% decline from 2022.
  • Merck total liabilities and share holders equity for 2022 was $109.16B, a 3.28% increase from 2021.
  • Merck total liabilities and share holders equity for 2021 was $105.694B, a 15.4% increase from 2020.

Merck Total Liabilities and Share Holders Equity 2010-2024 | MRK

  • Merck total liabilities and share holders equity for 2023 was $106.675B, a 2.28% decline from 2022.
  • Merck total liabilities and share holders equity for 2022 was $109.16B, a 3.28% increase from 2021.
  • Merck total liabilities and share holders equity for 2021 was $105.694B, a 15.4% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B